Document is current
Any future updates will be listed below
-
Authors
Liu, An-Bang
Zhang, Yu
Tian, Peng
Meng, Ting-Ting
Chen, Jian-Lin
Zhang, Dan
Zheng, Yan
Su, Guo-Hai
-
Funding
Funding for this research was provided by:
Internationally Standardized Tumor Immunotherapy and Key Technology Platform Construction for Clinical Trials of Drug-Induced Heart Injury (2020ZX09201025)
Internationally Standardized Tumor Immunotherapy and Key Technology Platform Construction for Clinical Trials of Drug-Induced Heart Injury (2020ZX09201025)
Jinan Medical Science and Technology Innovation Project (201805004)
Jinan Medical Science and Technology Innovation Project (201805004)
Science Fund for Distinguished Young Scholars of Shandong Province (ZR2021MH019)
Science Fund for Distinguished Young Scholars of Shandong Province (ZR2021MH019)
- License Information
-
More Information
Article History
Received: 17 September 2023
Accepted: 31 July 2024
First Online: 20 August 2024
Declarations
:
: The investigation was approved by the NCHS research ethics review board ().
: The authors declare no competing interests.
